In contrast to what we found for ROR1, the expression levels of ROR2 were lowest in HR-HER2- breast cancers and significantly lower than that found in other subtypes; the highest ROR2 expression levels were observed in the HR + HER2 + subtype, Fig. 1b. This evidence concerns the gene ROR2 and breast cancer.